AURYXIA
Peakferric citrate
NDAORALTABLET
Approved
Sep 2014
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
2
Mechanism of Action
phosphate. This compound is insoluble and is excreted in the stool. By binding phosphate in the GI tract and decreasing absorption, ferric citrate lowers the phosphate concentration in the serum. Iron Deficiency Anemia in Chronic Kidney Disease Not on Dialysis Ferric iron is reduced from the ferric…
Clinical Trials (2)
Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease
Started Mar 2022
Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants
Started Jun 2021
Loss of Exclusivity
LOE Date
Jul 21, 2030
53 months away
Patent Expiry
Jul 21, 2030